言語を選択
新規登録

SHP-2

SHP-2 詳細

英語名Src homology phosphotyrosyl phosphatase 2市販薬剤の数0
治験薬の数21ターゲットの別称Protein Tyrosine Phosphatase Non-Receptor Type 11，SHP-2，PTP2C，Protein-tyrosine phosphatase 2C，PTP-2C，PTP-1D，SH-PTP3，PTPN11，Protein-Tyrosine Phosphatase 1D，SH-PTP2，EC:3.1.3.48，Noonan Syndrome 1，EC 3.1.3.48，METCDS，SHPTP2，BPTP3，JMML，SHP2，CFC，NS1，Protein Tyrosine Phosphatase， Non-Receptor Type 11，Tyrosine-Protein Phosphatase Non-Receptor Type 11
研究＆開発段階Phase 3 Clinical
英語名Src homology phosphotyrosyl phosphatase 2
ターゲットの別称Protein Tyrosine Phosphatase Non-Receptor Type 11，SHP-2，PTP2C，Protein-tyrosine phosphatase 2C，PTP-2C，PTP-1D，SH-PTP3，PTPN11，Protein-Tyrosine Phosphatase 1D，SH-PTP2，EC:3.1.3.48，Noonan Syndrome 1，EC 3.1.3.48，METCDS，SHPTP2，BPTP3，JMML，SHP2，CFC，NS1，Protein Tyrosine Phosphatase， Non-Receptor Type 11，Tyrosine-Protein Phosphatase Non-Receptor Type 11
市販薬剤の数0
治験薬の数21
研究＆開発段階Phase 3 Clinical

SHP-2 製品リスト

  • 属性

    Protein (1)

  • 製品ライブラリ

    オンライン (1)

  • 種

    Human (1)

  • タグ

    His Tag (1)

  • マーカー

    Unconjugated (1)

製品番号種発現システム製品説明タンパク質の構造純度特性
SH2-H5248
Human
E. coli
Human SHP-2 Protein, His Tag
総数量1
  • 1

SHP-2バックグランド

SHP-2, a cytoplasmic SH2 domain containing protein tyrosine phosphatase, is involved in the signaling pathways of a variety of growth factors and cytokines. SHP-2 takes key role in transducing signal relay from the cell surface to the nucleus, and is a important intracellular regulator in mediating cell proliferation and differentiation.

SHP-2分子の別称

SHP-2

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
SitneprotafibJAB-3312; AST24082Phase 3 ClinicalJacobio Pharmaceuticals Co LtdBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
JAB-3068JAB-3068Phase 2 ClinicalAbbvie Inc, Jacobio Pharmaceuticals Co LtdCarcinoma, Adenoid Cystic; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Head and Neck Neoplasms; Lymphoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
VociprotafibRMC-4630; SAR-442720Phase 2 ClinicalRevolution Medicines Inc, SanofiCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Solid tumours
詳細
BatoprotafibTNO-155Phase 2 ClinicalNovartis Pharma AgCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Gastrointestinal Stromal Tumors; Hepatic Insufficiency; Lung Neoplasms; Melanoma; Neoplasm Metastasis; Neoplasms; Renal Insufficiency; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
GH-21GH 21005; GH-21; HBI-2376Phase 2 ClinicalSuzhou Genhouse Bio Co LtdCarcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours
詳細
BR-790BR-790Phase 2 ClinicalJiangxi Qingfeng Pharmaceutical Industry Co LtdCarcinoma, Non-Small-Cell Lung; Neoplasms; Solid tumours
詳細
ERAS-601ERAS-601Phase 2 ClinicalNiKang Therapeutics IncChordoma; Leukemia, Myeloid, Acute; Solid tumours
詳細
BBP-398IACS-15509; BBP-398; IACS-13909; BMS-986466Phase 2 ClinicalBridgebio Pharma Inc, The University Of Texas MD Anderson Cancer CenterCarcinoma, Non-Small-Cell Lung; Solid tumours
詳細
MigoprotafibRLY-1971; GDC-1971; RO-7517834; RG-6433Phase 1 ClinicalRelay Therapeutics IncCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Solid tumours
詳細
A-380A-380Phase 1 ClinicalKlus Pharma Inc, Shandong Kelun Phaemaceutical Co LtdNeoplasms
詳細
KYHY-2303KYHY2303; KYHY-2303Phase 1 ClinicalJiangsu Kanion Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of SciencesHematologic Neoplasms
詳細
RG-001RG001; RG-001Phase 1 ClinicalRudong Ringene Pharmaceuticals Co Ltd, Shanghai Lingji Biological Technology Co LtdNeoplasms
詳細
HS-336HS336; HS-336Phase 1 ClinicalZhejiang Hisun Pharmaceutical Co LtdSolid tumours
詳細
HMPL-415S1HMPL-415S1Phase 1 ClinicalSolid tumours
詳細
PH-005PH005; PH-005Phase 1 ClinicalSuzhou Puhe Pharmaceutical Technology Co LtdSolid tumours
詳細
BPI-442096Phase 1 ClinicalBetta Pharmaceuticals Co LtdCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Pancreatic Neoplasms; Solid tumours
詳細
HS-10381HS-10381Phase 1 ClinicalJiangsu Hansoh Pharmaceutical Group Co LtdSolid tumours
詳細
ET-0038ET-0038Phase 1 ClinicalEtern BioPharma (Shanghai) Co LtdSolid tumours
詳細
PF-07284892ARRY-558; PF-07284892Phase 1 ClinicalPfizer IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Solid tumours
詳細
ICP-189ICP-189Phase 1 ClinicalInnoCare Pharma LtdCarcinoma, Non-Small-Cell Lung; Solid tumours
詳細
SH-3809SH3809Phase 1 ClinicalNanjing Sanhome Pharmaceutical Co Ltd Solid tumours
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
共有：

採用情報法的規制サイトマッププライバシーポリシー利用規約
ウェブサイトに関するフィードバック
お問い合わせ

お問い合わせ
グローバル：+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8